PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

TGen study finds genes associated with improved survival for pancreatic cancer patients

Use of non-invasive liquid biopsies could predict in which patients the cancer could recur following surgery

2015-08-20
(Press-News.org) PHOENIX, Ariz. -- Aug. 20, 2015 -- A study by the Translational Genomics Research Institute (TGen) and other major research institutes, found a new set of genes that can indicate improved survival after surgery for patients with pancreatic cancer. The study also showed that detection of circulating tumor DNA in the blood could provide an early indication of tumor recurrence.

In conjunction with the Stand Up To Cancer (SU2C) Pancreatic Cancer Dream Team, the study was published in the prestigious scientific journal Nature Communications.

Using whole-exome sequencing -- looking at the DNA protein-coding regions of 24 tumors -- and targeted genomic analyses of 77 other tumors, the study identified mutations in chromatin-regulating genes MLL, MLL2, MLL3 and ARID1A in 20 percent of patients associated with improved survival.

In addition, using a liquid biopsy analysis, the study found that 43 percent of pancreatic cancer patients had circulating tumor DNA (ctDNA) in their bloodstream at the time of diagnosis.

Very importantly, the study also found that detection of ctDNA following surgery predicts clinical relapse of the cancer and poor outcomes for patients. In addition, using a liquid biopsy detected the recurrence of cancer 6.5 months earlier than using CT imaging.

"These observations provide predictors of outcomes in patients with pancreatic cancer and have implications for detection of tumor recurrence, and perhaps someday for early detection of the cancer," said Dr. Daniel D. Von Hoff, TGen Distinguished Professor and Physician-In-Chief, Co-Director of TGen's SU2C Pancreatic Cancer Dream Team, and Chief Scientific Officer at the Virginia G. Piper Cancer Center Clinical Trials at HonorHealth (formerly Scottsdale Healthcare). Dr. Von Hoff was one of the authors of the study.

The pancreatic cancers analyzed in the study were stage II tumors from patients who underwent potentially curative surgery. Only 15-20 percent of patients are candidates for tumor resection, because pancreatic cancer is difficult to detect and usually is not diagnosed until its late stages when surgery is no longer an option. The 5-year survival rate for those diagnosed with pancreatic cancer is less than 10 percent.

The study's results found that a significant number of early-stage pancreatic cancers could be diagnosed non-invasively using liquid biopsy blood analysis that focuses on a few specific genetic alterations.

"We have identified MML genes as markers of improved prognosis for patients with pancreatic cancer," Dr. Von Hoff said. "We have also shown that ctDNA in the blood of pancreatic cancer patients may provide a marker of earlier detection of recurrence of the disease."

The study -- Clinical implications of genomic alterations in the tumor and circulation of pancreatic cancer patients -- was published July 7.

This analysis suggests that additional studies should "evaluate more intensive therapies" for patients without MLL mutations or with detectable ctDNA following surgical removal of their tumors, as well as interventional clinical trials, the study said.

INFORMATION:

Other participants in this study included: Johns Hopkins University School of Medicine, Mayo Clinic, and Memorial Sloan Kettering Cancer Center.

About TGen Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with cancer, neurological disorders and diabetes, through cutting edge translational research (the process of rapidly moving research towards patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, visit: http://www.tgen.org.

Press Contact: Steve Yozwiak
TGen Senior Science Writer
602-343-8704
syozwiak@tgen.org



ELSE PRESS RELEASES FROM THIS DATE:

Experiment attempts to snare a dark energy 'chameleon'

Experiment attempts to snare a dark energy chameleon
2015-08-20
If dark energy is hiding in our midst in the form of hypothetical particles called "chameleons," Holger Müller and his team at the University of California, Berkeley, plan to flush them out. The results of an experiment reported in this week's issue of Science narrows the search for chameleons a thousand times compared to previous tests, and Müller, an assistant professor of physics, hopes that his next experiment will either expose chameleons or similar ultralight particles as the real dark energy, or prove they were a will-o'-the-wisp after all. Dark energy ...

Boreal forests challenged by global change

2015-08-20
Management of boreal forests needs greater attention from international policy, argued forestry experts from the International Institute for Applied Systems Analysis (IIASA), Natural Resources Canada, and the University of Helsinki in Finland in a new article published this week in the journal Science. The article, which reviews recent research in the field, is part of a special issue on forests released in advance of the World Forestry Congress in September. "Boreal forests have the potential to hit a tipping point this century," says IIASA Ecosystems Services and Management ...

Humans as predators: An unsustainable appetite for adults and carnivores

Humans as predators: An unsustainable appetite for adults and carnivores
2015-08-20
This news release is available in Japanese. Humans are just one of many predators in this world, but a new study highlights how their intense tendency to target and kill adult prey, as well as other carnivores, sets them distinctly apart from other predators. As humans kill other species in their reproductive prime, there can be profound implications -- including widespread extinction and restructuring of food webs and ecosystems--in both terrestrial and marine systems. To evaluate the nature of human predation compared to nonhuman predation, Chris Darimont et al. conducted ...

Special issue: Forest health

Special issue: Forest health
2015-08-20
This news release is available in Japanese. In this special issue, the editors of Science invite experts to provide closer looks at how natural and human-induced environmental changes are affecting forests around the world, from the luscious, diverse forests of the tropics, to the pristine, resilient boreal forests of the north. The special issue is complemented by a package from Science's news department. Amid extreme environmental and climate changes, Susan Trumbore and colleagues highlight the urgency of monitoring forest health, especially ...

Disagreement among experts over bioweapons threat

2015-08-20
This news release is available in Japanese. Amid continued difficulties around assessing bioweapons threats, especially given limited empirical data, Crystal Boddie and colleagues took another route to gauge their danger: the collective judgment of multiple experts. The experts' opinions on bioweapons-related risks were quite diverse, the Policy Forum authors say, adding to the challenge around developing a regulatory system for legitimate dual use research. Boddie et al. explain how they employed a Delphi Method study to query the beliefs and opinions of 59 experts ...

Unique genes in Khoe-San people may lower risk of some pregnancy hazards

2015-08-20
An examination of the immune genes of the southern African Khoe-San people has revealed a completely new kind of mutation, according to researchers at the Stanford University School of Medicine. The gene variant likely contributes to healthier babies, although the variant can also lower resistance to disease. The findings grew out of a long-term effort by Peter Parham, PhD, professor of structural biology and of microbiology and immunology, to understand how immune system genes make us reject organ transplants. A paper detailing the findings will be published online ...

Regulatory, certification systems creating paralysis in use of genetically altered trees

2015-08-20
CORVALLIS, Ore. - Myriad regulations and certification requirements around the world are making it virtually impossible to use genetically engineered trees to combat catastrophic forest threats, according to a new policy analysis published this week in the journal Science. In the United States, the time is ripe to consider regulatory changes, the authors say, because the federal government recently initiated an update of the overarching Coordinated Framework for the Regulation of Biotechnology, which governs use of genetic engineering. North American forests are suffering ...

The unique ecology of human predators

The unique ecology of human predators
2015-08-20
Are humans unsustainable 'super predators'? Want to see what science now calls the world's "super predator"? Look in the mirror. Research published today in the journal Science by a team led by Dr. Chris Darimont, the Hakai-Raincoast professor of geography at the University of Victoria, reveals new insight behind widespread wildlife extinctions, shrinking fish sizes and disruptions to global food chains. "These are extreme outcomes that non-human predators seldom impose," Darimont's team writes in the article titled "The Unique Ecology of Human Predators." "Our ...

Discovery of trigger for bugs' defenses could lead to new antibiotics

2015-08-20
Scientists have exposed a chink in the armour of disease-causing bugs, with a new discovery about a protein that controls bacterial defences. Bacteria react to stressful situations - such as running out of nutrients, coming under attack from antibiotics or encountering a host body's immune system - with a range of defence mechanisms. These include constructing a resistant outer coat, growing defensive structures on their surface or producing enzymes that break down the DNA of an attacker. The new research shows that a protein called sigma54 holds a bacterium's defences ...

A detector shines in search for dark matter

2015-08-20
WEST LAFAYETTE, Ind. -- Results of the XENON100 experiment are a bright spot in the search for dark matter. The team of international scientists involved in the project demonstrated the sensitivity of their detector and recorded results that challenge several dark matter models and a longstanding claim of dark matter detection. Papers detailing the results will be published in upcoming issues of the journals Science and Physical Review Letters. Dark matter is an abundant but unseen matter in the universe considered responsible for the gravitational force that keeps the ...

LAST 30 PRESS RELEASES:

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

[Press-News.org] TGen study finds genes associated with improved survival for pancreatic cancer patients
Use of non-invasive liquid biopsies could predict in which patients the cancer could recur following surgery